Our findings could explain the prevalence of bleeding symptoms, particularly mucosal hemorrhages, and are in line with another study reporting reduced ATP release in platelets from COVID-19 patients after stimulation with thrombin receptor activating peptide [29]. Here, F2R is linked to COVID-19.